Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine

被引：0
|
作者：
Ralf Buettner
Le Xuan Truong Nguyen
Corey Morales
Min-Hsuan Chen
Xiwei Wu
Lisa S. Chen
Dinh Hoa Hoang
Servando Hernandez Vargas
Vinod Pullarkat
Varsha Gandhi
Guido Marcucci
Steven T. Rosen
机构：
[1] City of Hope Medical Center,Hematology Malignancies Research Institute, Gehr Family Center for Leukemia Research
[2] City of Hope Medical Center,Integrative Genomics Core, Beckman Research Institute
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
来源：
Journal of Hematology & Oncology | / 14卷
关键词：
Acute myeloid leukemia; Oxidative phosphorylation; Fatty acid oxidation; Nucleoside analog; Metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia
    Fleischmann, Maximilian
    Jentzsch, Madlen
    Brioli, Annamaria
    Eisele, Florian
    Frietsch, Jochen J.
    Eigendorff, Farina
    Tober, Romy
    Schrenk, Karin G.
    Hammersen, Jakob Friedrich
    Yomade, Olaposi
    Hilgendorf, Inken
    Hochhaus, Andreas
    Scholl, Sebastian
    Schnetzke, Ulf
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 285 - 294
  • [32] Metabolic Reprogramming of Acute Myeloid Leukemia Blasts By Bone Marrow Stroma Cells
    Mougiakakos, Dimitrios
    Jitschin, Regina
    Braun, Martina
    Mackensen, Andreas
    BLOOD, 2014, 124 (21)
  • [33] Metabolic reprogramming of acute myeloid leukemia blasts by bone marrow stromal cells
    Braun, M.
    Jitschin, R.
    Mackensen, A.
    Mougiakakos, D.
    Oncology Research and Treatment, 2015, 38 : 50 - 50
  • [34] Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients
    Chatzikalil, Elena
    Roka, Kleoniki
    Diamantopoulos, Panagiotis T.
    Rigatou, Efthymia
    Avgerinou, Georgia
    Kattamis, Antonis
    Solomou, Elena E.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [35] OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid Leukemia
    Wilde, Lindsay
    Martinez-Outschoorn, Ubaldo
    Palmisiano, Neil
    Kasner, Margaret
    BLOOD, 2019, 134
  • [36] Hypomethylating Agents in Combination with Venetoclax As a Bridge to Allogeneic Transplant in Acute Myeloid Leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Gaut, Daria
    Mittal, Varun
    Oliai, Caspian
    Muffly, Lori S.
    Logan, Aaron C.
    Mannis, Gabriel N.
    BLOOD, 2020, 136
  • [37] Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia
    Liu, Qingyang
    Zhang, Xiawei
    Lv, Lei
    Xu, Linming
    Jing, Yu
    Gao, Wenjing
    Wang, Lili
    Dou, Liping
    CANCER MEDICINE, 2025, 14 (05):
  • [38] The Effect and Mechanism of Venetoclax in Combination with SAR405 in Acute Myeloid Leukemia
    Li, Youhong
    Jiang, Xia
    Jiang, Lei
    Lu, Ying
    Jin, Jie
    Pei, Renzhi
    BLOOD, 2024, 144 : 5816 - 5817
  • [39] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [40] Limited efficacy of Venetoclax Combination Regimens in Acute Myeloid Leukemia with Extramedullary Relapse
    Bae, Soyoung
    Sa, Seungwon
    Park, Silvia
    Cho, Byung-Sik
    Kim, Hee-Je
    ACTA HAEMATOLOGICA, 2023, : 352 - 359
12345